Malvern Extends Contract Services in France
News May 25, 2006
Malvern Instruments has extended its provision of contract testing services for particle characterization in France following the conclusion of an agreement with the Laboratoire de Genie Chimique (LGC) based in Toulouse.
The agreement covers services related to both wet and dry particle size analysis. Testing will be carried out by LGC scientists and technicians skilled in the application of advanced particle sizing techniques.
Enquiries about contract services and the initiation of projects will continue to be handled in the first instance by Malvern’s application specialists. Full details can be found on Malvern’s website or by telephoning the company.
Commenting on the new relationship, Jane Bishop, Malvern’s Commercial Director, said, "We are delighted to welcome LGC as a partner as Malvern expands its provision of contract services in France."
"In addition to bringing extensive experience and expertise in particle characterization, LGC’s university connections will help inform our future work to ensure that we offer comprehensive testing services appropriate to the needs of both commercial and academic organisations."
Dr. Joel Bertrand, head of the LGC department said, "Our researchers and technicians have developed considerable expertise, over a long period, in the characterization of dispersed media, mostly using Malvern equipment."
"We believe that this agreement will help us to apply this expertise and extend it to new techniques."
"In addition, we very much expect that via new contacts with the client companies, we will have new opportunities to develop our research in process engineering."
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE